Rowin mentions it in his post, which references the Fosters broker report dated March 27, 2014.
"YOW has significantgrowth potential. The growth potential for YOW is substantial yet simple.
Based on 40m unit sales (production capacity as September 2014), $0.30 per unit EBIT margin and an earnings multiple of 17 times we derive a valuation of $168m or $1.21/sh.
At annual ised sales of 200m units the valuation increases to $5.40/sh,demonstrating the upside potential of the company. Post the recent raising YOW has $11m cash and is funded for growth"
It seems odd to me their valuation is so low.
- Forums
- ASX - By Stock
- YOWIE options
Rowin mentions it in his post, which references the Fosters...
Featured News
Add YOW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.734M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
YOW (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online